CFM
Catalyst Funds Management Portfolio holdings
AUM
$362M
1-Year Return
42.71%
This Quarter Return
-3.7%
1 Year Return
+42.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$382M
AUM Growth
-$22.3M
(-5.5%)
Cap. Flow
-$13.2M
Cap. Flow
% of AUM
-3.45%
Top 10 Holdings %
Top 10 Hldgs %
18.96%
Holding
611
New
314
Increased
64
Reduced
61
Closed
162
Top Buys
| 1 |
NVIDIA
NVDA
|
$13.1M |
| 2 |
Pfizer
PFE
|
$7.17M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$5.18M |
| 4 |
Blackrock
BLK
|
$5.07M |
| 5 |
eBay
EBAY
|
$4.8M |
Top Sells
| 1 |
Broadcom
AVGO
|
$35.5M |
| 2 |
Meta Platforms (Facebook)
META
|
$32.4M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$11.4M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
$10.7M |
| 5 |
Cisco
CSCO
|
$8.73M |
Sector Composition
| 1 | Financials | 17.62% |
| 2 | Technology | 15.49% |
| 3 | Industrials | 13.5% |
| 4 | Healthcare | 12.12% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MFH
401
Mercurity Fintech Holding
MFH
$386M
| $74K | 0.02% |
+13,800
| New | +$74K |
|
402
Protalix BioTherapeutics
PLX
$123M
| $69.5K | 0.02% |
27,139
+16,939
| +166% | +$43.4K |
|
|
AIOT
403
PowerFleet, Inc. Common Stock
AIOT
$670M
| $69.2K | 0.02% |
+12,600
| New | +$69.2K |
|
404
Gevo
GEVO
$404M
| $65.3K | 0.02% |
56,300
-4,500
| -7% | -$5.22K |
|
405
Trinseo
TSE
$88.1M
| $63.6K | 0.02% |
+17,285
| New | +$63.6K |
|
406
Community Health Systems
CYH
$409M
| $62.6K | 0.02% |
+23,200
| New | +$62.6K |
|
407
Arq
ARQ
$302M
| $62.6K | 0.02% |
+15,000
| New | +$62.6K |
|
408
Ginkgo Bioworks
DNA
$660M
| $57.8K | 0.02% |
+10,146
| New | +$57.8K |
|
409
Gossamer Bio
GOSS
$668M
| $57.2K | 0.02% |
+52,039
| New | +$57.2K |
|
|
ATYR
410
aTyr Pharma
ATYR
$550M
| $54.2K | 0.01% |
+17,953
| New | +$54.2K |
|
411
Citizens
CIA
$262M
| $54.1K | 0.01% |
+11,900
| New | +$54.1K |
|
412
Amylyx Pharmaceuticals
AMLX
$910M
| $52.8K | 0.01% |
+14,905
| New | +$52.8K |
|
|
NAK
413
Northern Dynasty Minerals
NAK
$466M
| $49.6K | 0.01% |
43,140
| – | – |
|
|
QD
414
Qudian
QD
$733M
| $48.2K | 0.01% |
+17,900
| New | +$48.2K |
|
|
RERE
415
ATRenew
RERE
$968M
| $47.9K | 0.01% |
+16,300
| New | +$47.9K |
|
416
Eledon Pharmaceuticals
ELDN
$162M
| $46.2K | 0.01% |
+13,620
| New | +$46.2K |
|
417
Gannett
GCI
$629M
| $45.1K | 0.01% |
+15,600
| New | +$45.1K |
|
418
United States Antimony
UAMY
$561M
| $43.9K | 0.01% |
+19,966
| New | +$43.9K |
|
419
Expensify
EXFY
$178M
| $43.8K | 0.01% |
+14,416
| New | +$43.8K |
|
420
Seer Inc
SEER
$118M
| $42.9K | 0.01% |
25,361
+13,361
| +111% | +$22.6K |
|
421
Blue Ridge Bankshares
BRBS
$374M
| $40.4K | 0.01% |
+12,399
| New | +$40.4K |
|
422
SKYX Platforms
SKYX
$133M
| $38.1K | 0.01% |
33,451
+17,651
| +112% | +$20.1K |
|
423
Sangamo Therapeutics
SGMO
$165M
| $35.7K | 0.01% |
+54,385
| New | +$35.7K |
|
424
KORU Medical Systems
KRMD
$188M
| $35K | 0.01% |
+13,777
| New | +$35K |
|
425
Microvast
MVST
$829M
| $33.8K | 0.01% |
+28,877
| New | +$33.8K |
|